98%
921
2 minutes
20
Objective: Examine factors associated with postprocedure opioid receipt and persistent opioid use among opioid-naive patients in a nationally representative sample.
Summary Background Data: We used panels 18-20 in the Medical Expenditures Panel Survey (MEPS) between the years 2013 and 2015. Respondents ages 18 and over with any self-reported procedure in the previous year with complete data on the outcome variables for the remainder of the 2-year study period.
Methods: This prospective observational study used multivariable regression to determine factors associated with postprocedure opioid receipt and persistent opioid use among opioid-naive patients, adjusting for sociodemographic, health, and procedure-related characteristics.
Results: Adjusted models showed younger age, Western location (AOR = 1.38; 95% CI = 1.02, 1.86), and high-school degree (AOR = 1.60; CI = 1.14, 2.26) were associated with higher odds of postprocedure opioid receipt. Patients who had procedures in an inpatient (AOR: 5.71; CI: 4.31-7.56), outpatient (AOR = 3.77; CI = 2.87,4.95), and dental setting (AOR = 2.86; CI = 1.45, 5.63), and musculoskeletal diagnoses (AOR = 2.23; CI = 1.39, 3.58) and injuries (AOR = 2.04; CI = 1.29, 3.23) were more likely to have postprocedure opioid receipt. Persistent opioid use was associated with Midwest (AOR = 2.06; CI = 1.08, 3.95) and Northeast location (AOR = 2.45; CI = 1.03, 3.95), musculoskeletal diagnosis (AOR = 3.91; CI = 1.23, 8.31), public insurance (AOR = 2.07; CI = 1.23-3.49), and positive depression screener (AOR = 3.36; CI = 2.04, 5.55).
Conclusions: Procedures account for a large portion of opioid prescriptions among opioid-naive patients. This study provides evidence to inform national guidelines for opioid prescribing and postprocedure pain management.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1097/SLA.0000000000004630 | DOI Listing |
Exp Clin Psychopharmacol
September 2025
Department of Neuroscience, Rockefeller Neuroscience Institute, West Virginia University School of Medicine.
Nearly 2 million people had a diagnosis of methamphetamine use disorder (MUD) in 2023 and overdose deaths involving psychostimulants are increasing. Given that there are no currently approved U.S.
View Article and Find Full Text PDFJ Pain Res
August 2025
Department of Anesthesiology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
Background: To evaluate the analgesic effects between thoracic epidural block (TEB) and conscious sedation with intercostal nerve block (CSINB) in patients undergoing thermal lung tumor ablation.
Methods: Medical records of patients with primary or secondary lung tumors who underwent thermal lung tumor ablation between 2011 and 2022 were reviewed. Primary outcome measures were pain intensity evaluated using the visual analog scale (VAS) and additional morphine use within 48 hours after the procedure.
Pain Physician
July 2025
Department of Pain Medicine, University of Texas, MD Anderson Cancer Center, Houston, TX.
Background: Celiac plexus or splanchnic nerve neurolysis is a treatment modality commonly offered for cancer-related upper abdominal pain. The optimal spinal level for performing celiac/splanchnic sympathetic neurolysis remains unclear.
Objective: We aimed to assess the outcome, effectiveness, and complications associated with undergoing splanchnic sympathetic neurolysis at various spinal levels for treating intractable upper abdominal cancer pain.
Open Respir Arch
July 2025
Department of Pulmonology, St. Elisabethen Krankenhaus, Frankfurt, Germany.
Introduction: Pleuroscopy is a minimally invasive and highly effective procedure used for diagnosing pleural diseases. Despite its utility, pain during and after the procedure can be significant. Traditional analgesic approaches, including systemic opioids and local anaesthetics albeit potent, may provide incomplete pain relief and can be associated with side effects.
View Article and Find Full Text PDFPain Med
June 2025
Department of Palliative Medicine, Poznan University of Medical Sciences, Poznań, Poland.
Background: Knee osteoarthritis (OA) is a leading cause of chronic pain and disability, particularly in patients with symptomatic disease. While total knee arthroplasty (TKA) remains the standard treatment for advanced OA, many patients, especially older adults, are not suitable surgical candidates due to comorbidities or limited access to care. Minimally invasive options, such as chemical neurolysis of the superomedial genicular nerve (SMGN), superolateral genicular nerve (SLGN), recurrent tibial genicular nerve (RTGN), and inferomedial genicular nerve (IMGN), may offer meaningful pain relief and improved quality of life for this population.
View Article and Find Full Text PDF